IL6 and prostate cancer: The results from a similar longitudinal study of cytokine expression patterns suggested that serum levels of IL-1, IL-2, IL-6 and IFN-γ in patients with prostate cancer during intensity-modulated radiotherapy may be predictive for acute radiation-induced normal tissue toxicity5.